isomethyleugenol has been researched along with lansoprazole in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Girre, C; Padoin, C; Palombo, S; Rizzo, N; Scherrmann, JM | 1 |
| Pertino, MW; RodrÃguez, JA; Schmeda-Hirschmann, G; Theoduloz, C | 1 |
1 trial(s) available for isomethyleugenol and lansoprazole
| Article | Year |
|---|---|
Omeprazole and lansoprazole are not inducers of cytochrome P4501A2 under conventional therapeutic conditions.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Anti-Ulcer Agents; Caffeine; Cross-Over Studies; Cytochrome P-450 CYP1A2; Cytochrome P-450 Enzyme System; Enzyme Induction; Enzyme Inhibitors; Female; Humans; Hydroxylation; Lansoprazole; Male; Methylation; Middle Aged; Omeprazole; Oxidoreductases; Proton Pump Inhibitors | 1996 |
1 other study(ies) available for isomethyleugenol and lansoprazole
| Article | Year |
|---|---|
Gastroprotective effect and cytotoxicity of carnosic acid derivatives.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abietanes; Animals; Anti-Ulcer Agents; Antioxidants; Cell Line; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Inhibitory Concentration 50; Lansoprazole; Male; Methylation; Mice; Plant Components, Aerial; Plant Extracts; Random Allocation; Rosmarinus; Stomach Ulcer; Structure-Activity Relationship | 2011 |